Ann Surg7 May 2026
This study shows that minimally invasive pancreatoduodenectomy (mipd) and open pancreatoduodenectomy (opd) yield similar outcomes for ampullary adenocarcinoma, regardless of subtype.
Ann Surg7 May 2026
This suggests LTN could be the preferred choice for managing walled-off necrosis in select patients.
Ann Surg7 May 2026
A new computer vision algorithm shows promise in predicting superior mesenteric artery margin status for pancreatic ductal adenocarcinoma, which could reshape surgical decision-making.
Ann Surg Oncol6 May 2026
Surgeons need to know that recent trends show increasing use of imprecise terms for pancreatic head resections, which can impact clinical understanding.
Ann Surg5 May 2026
Achieving a major pathologic response (mpr) after preoperative treatment for pancreatic ductal adenocarcinoma significantly impacts survival rates.
Ann Surg Oncol5 May 2026
Patients with isolated pulmonary metastases post-resection of pancreatic ductal adenocarcinoma (PDAC) have improved overall survival compared to other metastatic sites.
Dig Dis Sci5 May 2026
Targeted endoscopic approaches offer symptom relief in chronic pancreatitis but surgery is preferred for long-term outcomes.
Ann Surg Oncol4 May 2026
Postoperative pancreatic fistula (POPF) significantly hampers chemotherapy delivery in pancreatic cancer patients.
J Am Coll Surg30 Apr 2026
Frailty significantly raises the risk of death and readmission after pancreatic surgery, primarily through postoperative complications.
JAMA Surg30 Apr 2026
Early enteral nutrition (EEN) via nasojejunal tube reduces complications after pancreatoduodenectomy compared to oral nutrition (ON).